BTA will move up in price when Relenza restocking restarts.
IMO restocking is being managed by GSK to recommence until after July 2011 so as GSK does not have to book any June quarter royalty payments for full year 30/6/2011 and which will be payable to BTA in July 2011
Past history shows the September quarter is the active one.
Remember GSK has 190 doses on the shelf teady to roll.
That is around $4 billion in sales or $280 million in royalties.
The stockpile at GSK will not be wasted
The clock is ticking in our favour.
BTA Price at posting:
$1.19 Sentiment: LT Buy Disclosure: Held